Geneos Wealth Management’s iShares iBonds Dec 2024 Term Treasury ETF IBTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,537
Closed -$589K 2977
2024
Q3
$589K Buy
24,537
+309
+1% +$7.4K 0.02% 515
2024
Q2
$581K Buy
24,228
+1,211
+5% +$29K 0.03% 460
2024
Q1
$551K Sell
23,017
-1,079
-4% -$25.8K 0.03% 475
2023
Q4
$575K Sell
24,096
-259
-1% -$6.17K 0.03% 448
2023
Q3
$581K Buy
+24,355
New +$579K 0.03% 435

Other funds holding IBTE

Geneos Wealth Management's IBTE Position: Q4 2024 in Review

Geneos Wealth Management sold out of iShares iBonds Dec 2024 Term Treasury ETF (IBTE) in Q4 2024, closing a stake of 24,537 shares — an estimated $589K sold.

Geneos Wealth Management first reported a position in IBTE in Q3 2023 and held it in 5 quarters. The position peaked at $589K in Q3 2024. 5 funds tracked by Wall St. Rank hold IBTE as of Q4 2024.

  • Geneos Wealth Management reported no remaining iShares iBonds Dec 2024 Term Treasury ETF position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 24,537 iShares iBonds Dec 2024 Term Treasury ETF shares in Q4 2024, an estimated $589K.
  • Geneos Wealth Management first reported a position in iShares iBonds Dec 2024 Term Treasury ETF in Q3 2023 and held it in 5 quarters.
  • Geneos Wealth Management's iShares iBonds Dec 2024 Term Treasury ETF position peaked at $589K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Treasury ETF as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.